European Stocks Slip as Hot US Wage Inflation Fuels Hawkish Bets [Financial Post (Toronto, Ontario, Canada)]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Financial Post
Author of the article: You can save this article by registering for free here . Or sign-in if you have an account. (Bloomberg) — European stocks dropped after US wage inflation accelerated, adding to the view that price pressures remain too high and increasing the odds that the Federal Reserve will be in no rush to reduce interest rates. The Stoxx 600 Index was 0.7% lower by the close, with the auto sector trailing the pan-European benchmark as results from Volkswagen AG and Mercedes-Benz Group AG disappointed. Real estate and personal care stocks outperformed. Shares had been subdued all day on further evidence of sticky inflation that overshadowed better-than-expected growth data in Europe. Article content Article content Novo Nordisk A/S went from being one of the benchmark's biggest drags to its best performer after Eli Lilly & Co. raised its annual outlook for sales and profit as the company races to satisfy soaring demand for its blockbuster weight-loss and diabetes
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Hims & Hers' surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,' exec says [Fortune]Fortune
- Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next [Fortune]Fortune
- Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy [Forbes]Forbes
- Hims & Hers Adds Weight-Loss Injections, Stock Soars [Yahoo! Finance]Yahoo! Finance
- Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 5/3/24 - Beat
NVO
Sec Filings
- 5/17/24 - Form 6-K
- 5/17/24 - Form SD
- 5/15/24 - Form 6-K
- NVO's page on the SEC website